Search for Clinical Trial Results
Osteosarcoma - 28 Studies Found
Status | Study |
Completed |
Study Name: Development of Indices Predicting Response to Pre-operative Chemotherapy in Osteosarcoma Patients Condition: Osteosarcoma Date: 2008-05-27 |
Not yet recruiting |
Study Name: Therapy Trial to Determine the Safety and Efficacy of Heavy Ion Radiotherapy in Patients With Osteosarcoma Condition: Osteosarcoma Date: 2009-10-23 Interventions: Radiation: heavy ion radiotherapy (C12) Desired target of |
Completed |
Study Name: Chemotherapy for Patients With Osteosarcoma Condition: Osteosarcoma Date: 2007-08-29 Interventions: Drug: Pemetrexed 500 mg/m^2, IV every 21 days until disease progression, unacceptable toxicity, particip |
Active, not recruiting |
Study Name: A Placebo-Controlled Study of Saracatinib (AZD0530) in Patients With Recurrent Osteosarcoma Localized to the Lung Condition: Osteosarcoma Date: 2008-09-11 Interventions:
|
Completed |
Study Name: Genetic Biomarkers in Tissue Samples From Patients With Osteosarcoma Condition: Osteosarcoma Date: 2013-03-06 Interventions: Other: laboratory biomarker analysis Correlative studies |
RECRUITING |
Study Name: Atezolizumab and Cabozantinib for the Treatment of Adolescents and Young Adults With Recurrent or Metastatic Osteosarcoma, TACOS Study Condition: Locally Advanced Osteosarcoma Date: 2024-05-19 Interventions: Given IV |
RECRUITING |
Study Name: Natalizumab in Recurrent, Refractory or Progressive Pulmonary Metastatic Osteosarcoma Condition: Pulmonary Metastatic Osteosarcoma (pOS) Date: 2024-05-19 Interventions: Natalizumab is an FDA approved monotherapy for treatment of relapsing forms of MS.It is also indicated for inducing and maintaining clinical |
NOT_YET_RECRUITING |
Study Name: Study to Assess Safety and Efficacy of Vactosertib in Adolescents and Adults With Recurrent, Refractory or Progressive Osteosarcoma Condition: Osteosarcoma Date: 2024-05-19 Interventions: Vactosertib is given twice a day, five days on and two days off in four-week cycles.Vactosertib is a transforming growth factor-beta (TGF-?) typ |